Birdwatch Note
2024-11-18 17:46:38 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Onderzoek heeft aangetoond dat hydroxychloroquine (HCQ) geen levens redde tijdens de COVID-19-pandemie. Grootschalige studies laten zien dat het geen verbetering bracht in het ziekteverloop of de overlevingskansen. De bewering dat Rob Elens levens redde, is ongefundeerd. https://www.nature.com/articles/s41598-022-26053-w
Written by 2C2A095A371A70BBD225CB2BBA89976E480E928EAB5E2E90445FB07D6F64533F
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1858528599021605131
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1858567504303714814
- noteId - 1858567504303714814
- participantId -
- noteAuthorParticipantId - 2C2A095A371A70BBD225CB2BBA89976E480E928EAB5E2E90445FB07D6F64533F Participant Details
- createdAtMillis - 1731951998197
- tweetId - 1858528599021605131
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Onderzoek heeft aangetoond dat hydroxychloroquine (HCQ) geen levens redde tijdens de COVID-19-pandemie. Grootschalige studies laten zien dat het geen verbetering bracht in het ziekteverloop of de overlevingskansen. De bewering dat Rob Elens levens redde, is ongefundeerd. https://www.nature.com/articles/s41598-022-26053-w
Note Ratings
rated at | rated by | |
2024-11-18 18:52:01 -0600 | Rating Details | |
2024-11-18 17:36:59 -0600 | Rating Details | |
2024-11-18 17:04:02 -0600 | Rating Details | |
2024-11-18 16:45:56 -0600 | Rating Details | |
2024-11-18 16:44:36 -0600 | Rating Details | |
2024-11-18 16:37:05 -0600 | Rating Details | |
2024-11-18 16:16:09 -0600 | Rating Details | |
2024-11-18 15:22:48 -0600 | Rating Details | |
2024-11-18 15:19:35 -0600 | Rating Details | |
2024-11-18 15:05:36 -0600 | Rating Details | |
2024-11-18 15:00:56 -0600 | Rating Details | |
2024-11-18 15:00:33 -0600 | Rating Details | |
2024-11-18 14:23:03 -0600 | Rating Details | |
2024-11-18 14:10:40 -0600 | Rating Details | |
2024-11-18 14:02:29 -0600 | Rating Details | |
2024-11-18 14:00:21 -0600 | Rating Details | |
2024-11-18 13:50:16 -0600 | Rating Details | |
2024-11-18 13:41:08 -0600 | Rating Details | |
2024-11-18 13:40:51 -0600 | Rating Details | |
2024-11-18 13:32:17 -0600 | Rating Details | |
2024-11-18 13:30:02 -0600 | Rating Details | |
2024-11-18 13:27:55 -0600 | Rating Details | |
2024-11-18 13:27:46 -0600 | Rating Details | |
2024-11-18 13:26:45 -0600 | Rating Details | |
2024-11-18 13:24:09 -0600 | Rating Details | |
2024-11-18 13:21:30 -0600 | Rating Details | |
2024-11-18 13:18:53 -0600 | Rating Details | |
2024-11-18 12:35:41 -0600 | Rating Details | |
2024-11-18 12:35:14 -0600 | Rating Details | |
2024-11-18 12:33:46 -0600 | Rating Details | |
2024-11-18 12:29:05 -0600 | Rating Details | |
2024-11-20 16:52:23 -0600 | Rating Details | |
2024-11-20 05:13:55 -0600 | Rating Details | |
2024-11-20 02:18:03 -0600 | Rating Details | |
2024-11-19 12:34:13 -0600 | Rating Details | |
2024-11-19 12:20:17 -0600 | Rating Details | |
2024-11-19 10:14:22 -0600 | Rating Details | |
2024-11-19 06:00:31 -0600 | Rating Details | |
2024-11-19 04:59:00 -0600 | Rating Details | |
2024-11-19 02:57:45 -0600 | Rating Details | |
2024-11-19 01:11:16 -0600 | Rating Details | |
2024-11-18 22:09:53 -0600 | Rating Details | |
2024-11-23 05:31:24 -0600 | Rating Details | |
2024-11-21 02:39:43 -0600 | Rating Details | |
2024-11-18 23:31:33 -0600 | Rating Details | |
2024-12-05 03:18:40 -0600 | Rating Details | |
2024-11-19 17:09:13 -0600 | Rating Details | |
2024-11-19 05:33:24 -0600 | Rating Details | |
2024-11-19 04:46:51 -0600 | Rating Details | |
2024-11-19 03:09:10 -0600 | Rating Details | |
2024-11-19 02:39:01 -0600 | Rating Details | |
2024-11-19 01:54:24 -0600 | Rating Details | |
2024-11-18 23:10:57 -0600 | Rating Details | |
2024-11-18 23:07:13 -0600 | Rating Details | |
2024-11-18 16:24:11 -0600 | Rating Details | |
2024-11-18 16:19:40 -0600 | Rating Details | |
2024-11-18 15:37:28 -0600 | Rating Details | |
2024-11-18 15:20:34 -0600 | Rating Details | |
2024-11-18 15:00:48 -0600 | Rating Details | |
2024-11-18 14:35:27 -0600 | Rating Details | |
2024-11-18 13:59:02 -0600 | Rating Details | |
2024-11-18 13:44:12 -0600 | Rating Details | |
2024-11-18 13:39:27 -0600 | Rating Details | |
2024-11-18 13:35:39 -0600 | Rating Details | |
2024-11-18 13:35:37 -0600 | Rating Details | |
2024-11-18 13:26:44 -0600 | Rating Details | |
2024-11-18 13:25:20 -0600 | Rating Details | |
2024-11-18 13:24:39 -0600 | Rating Details | |
2024-11-18 13:17:44 -0600 | Rating Details |